This event gathers leading experts and professionals from the pharmaceutical and biotechnology sectors to delve into the complex and ever-evolving landscape of patent litigation in Europe.
Partner Ross Cummings will be speaking on a panel discussing recent antibody-related patent office decisions both in Europe and the US, with a particular focus on current best practices for drafting and examining antibody patents.
This conference aims to provide attendees with a comprehensive understanding of the current state of pharma and biotech patent litigation in Europe, equipping them with the knowledge to protect their innovations effectively and maintain a competitive edge in a rapidly advancing field.
If you are attending this event, we look forward to seeing you there.
Related resources
Navigating product-by-process claims at the European Patent Office
Inventions in the field of chemistry often relate to the discovery of a new product that has been...
Nobel Prize 2024: advancements in gene silencing via microRNA technology
This week, on 7 October 2024, it was announced that the 2024 Nobel Prize in Physiology or Medicine...
RNA therapeutics: a glance at the patent filing landscape
RNA therapeutics have cemented their position as a cornerstone of modern medicine since their crucial role in alleviating...